Advances in biologic therapies for COPD: precision medicine approaches and implications for small-airway disease

Biologic therapies offer promise for selected COPD phenotypes; however, their long-term impact will depend on precision medicine, optimized airway-targeted delivery, and integration with established inhaled treatments to achieve meaningful disease modification.